DexCom, Inc.
MX ˙ BMV ˙ US2521311074
SecurityMX:DXCM / DexCom, Inc.
InstitutionBKD Wealth Advisors, LLC
Latest Disclosed Ownership15,838 shares
Latest Disclosed Value $ 994,627
BKD Wealth Advisors, LLC reports 0.25% decrease in ownership of DXCM / DexCom, Inc.

On May 1, 2026 - BKD Wealth Advisors, LLC filed a 13F-HR form disclosing ownership of 15,838 shares of DexCom, Inc. (MX:DXCM) valued at $994,627 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 10, 2026 disclosing 15,877 shares of DexCom, Inc.. This represents a change in shares of -0.25% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-01 2026-03-31 13F DEXCOM COM 252131107 15,838 -39 -0.25 995 -5.60 0.0189
2026-02-10 2025-12-31 13F DEXCOM COM 252131107 15,877 814 5.40 1,054 3.95 0.0199
2025-10-30 2025-09-30 13F DEXCOM COM 252131107 15,063 -650 -4.14 1,014 -26.11 0.0201
2025-07-29 2025-06-30 13F DEXCOM COM 252131107 15,713 -1,768 -10.11 1,372 14.92 0.0296
2025-05-13 2025-03-31 13F DEXCOM COM 252131107 17,481 0 0.00 1,194 -12.21 0.0286
2025-02-04 2024-12-31 13F DEXCOM COM 252131107 17,481 118 0.68 1,359 16.75 0.0313
2024-11-14 2024-09-30 13F DEXCOM COM 252131107 17,363 680 4.08 1,164 -38.45 0.0268
2024-08-09 2024-06-30 13F DEXCOM COM 252131107 16,683 -5 -0.03 1,892 -18.28 0.0472
2024-04-19 2024-03-31 13F DEXCOM COM 252131107 16,688 307 1.87 2,315 13.88 0.0588
2024-01-11 2023-12-31 13F DEXCOM COM 252131107 16,381 110 0.68 2,033 33.86 0.0566
2023-10-26 2023-09-30 13F DEXCOM COM 252131107 16,271 -17 -0.10 1,518 -27.47 0.0458
2023-08-08 2023-06-30 13F DEXCOM COM 252131107 16,288 0 0.00 2,093 10.62 0.0613
2023-04-27 2023-03-31 13F DEXCOM COM 252131107 16,288 2 0.01 1,892 2.60 0.0620
2023-02-03 2022-12-31 13F DEXCOM COM 252131107 16,286 25 0.15 1,844 40.76 0.0645
2022-10-14 2022-09-30 13F DEXCOM COM 252131107 16,261 -67 -0.41 1,310 7.64 0.0529
2022-07-22 2022-06-30 13F DEXCOM COM 252131107 16,328 12,258 301.18 1,217 -41.55 0.0492
2022-05-10 2022-03-31 13F DEXCOM COM 252131107 4,070 0 0.00 2,082 -4.71 0.0882
2022-01-14 2021-12-31 13F DEXCOM COM 252131107 4,070 -1 -0.02 2,185 -1.84 0.0919
2021-10-14 2021-09-30 13F DEXCOM COM 252131107 4,071 2 0.05 2,226 28.15 0.1023
2021-07-14 2021-06-30 13F DEXCOM COM 252131107 4,069 -2 -0.05 1,737 18.73 0.0808
2021-04-23 2021-03-31 13F DEXCOM COM 252131107 4,071 -163 -3.85 1,463 -6.52 0.0727
2021-01-22 2020-12-31 13F DEXCOM COM 252131107 4,234 -48 -1.12 1,565 -11.33 0.0784
2020-11-05 2020-09-30 13F DEXCOM COM 252131107 4,282 32 0.75 1,765 2.44 0.1028
2020-07-15 2020-06-30 13F DEXCOM COM 252131107 4,250 47 1.12 1,723 52.21 0.1116
2020-04-10 2020-03-31 13F DEXCOM COM 252131107 4,203 -3 -0.07 1,132 23.04 0.0928
2020-01-13 2019-12-31 13F DEXCOM COM 252131107 4,206 57 1.37 920 48.63 0.0663
2019-10-28 2019-09-30 13F DEXCOM COM 252131107 4,149 0 0.00 619 -0.48 0.0495
2019-07-10 2019-06-30 13F DEXCOM COM 252131107 4,149 4 0.10 622 25.91 0.0504
2019-04-10 2019-03-31 13F DEXCOM COM 252131107 4,145 0 0.00 494 -0.60 0.0410
2019-01-28 2018-12-31 13F/A-1 DEXCOM COM 252131107 4,145 -19 -0.46 497 -16.61 0.0508
2019-01-15 2018-12-31 13F DEXCOM COM 252131107 4,145 -19 497 0.0460
2018-10-09 2018-09-30 13F DEXCOM COM 252131107 4,164 0 0.00 596 50.89 0.0522
2018-07-13 2018-06-30 13F DEXCOM COM 252131107 4,164 -65 -1.54 395 25.80 0.0384
2018-05-25 2018-03-31 13F/A-1 DEXCOM COM 252131107 4,229 75 1.81 314 31.93 0.0315
2018-04-20 2018-03-31 13F DEXCOM COM 252131107 4,164 10 306
2018-01-18 2017-12-31 13F DEXCOM COM 252131107 4,154 55 1.34 238 18.41 0.0238
2017-10-13 2017-09-30 13F DEXCOM COM 252131107 4,099 4,099 -1.32 201 -15.55 0.0221
2015-04-16 2015-03-31 13F DEXCOM COM 252131107 0 -5,083 -100.00 0 -100.00
2015-01-15 2014-12-31 13F DEXCOM COM 252131107 5,083 83 1.66 300 40.85 0.0464
2014-10-10 2014-09-30 13F DEXCOM COM 252131107 5,000 0 0.00 213 2.90 0.0347
2014-04-29 2014-03-31 13F DEXCOM COM 252131107 5,000 -5,000 -50.00 207 -41.53 0.0366
2014-01-13 2013-12-31 13F DEXCOM COM 252131107 10,000 0 0.00 354 25.53 0.0298
2013-11-14 2013-09-30 13F DEXCOM COM 252131107 10,000 10,000 282 0.0282
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.